Fengyan Jin

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Venues

Annals of hematology

American journal of hematology

Journal of hematology & oncology

Blood cancer journal

Jilin University First Hospital

Chinese Academy of Medical Sciences and Peking Union Medical College (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jilin University First Hospital Dec 01 2016

China

Professor :: Hematology/Oncology

Jilin University First Hospital Nov 15 2012 - Dec 01 2016

China

Associate Professor :: Hematology/Oncology

Universität Duisburg-Essen - Campus Essen Dec 15 2008 - Oct 01 2012

Germany

Post-Doc Research Fellow :: Physiology

Jilin Cancer Hospital Aug 01 2005 - Nov 30 2008

China

Attending Physician :: Hematology/Oncology

Affiliated Hospital of Jilin Medical College Aug 01 1995 - Aug 30 1997

China

Physician :: Cardiology

Education History

Chinese Academy of Medical Sciences and Peking Union Medical College Sep 01 2002 - Jul 30 2005

China

PHD :: Medicine

Jilin Medical College Sep 01 1997 - Aug 30 2002

China

MSC :: Medicine

Publications

Yingjie Zhang, Xinyue Liang, Weiling Xu, Xingcheng Yi, Rui Hu, Xintian Ma, Yurong Yan, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Yufeng Zhu, Mengru Tian, Maozhuo Lan, Mengtuan Long, Yun Dai, Fengyan Jin
Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study. Journal of hematology & oncology 17 (1) (2024)
Yingjie Zhang, Xinyue Liang, Weiling Xu, Xingcheng Yi, Rui Hu, Xintian Ma, Yurong Yan, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Yufeng Zhu, Mengru Tian, Maozhuo Lan, Mengtuan Long, Yun Dai, Fengyan Jin
Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study. Journal of hematology & oncology 17 (1) (2024)
Yingjie Zhang, Xinyue Liang, Weiling Xu, Xingcheng Yi, Rui Hu, Xintian Ma, Yurong Yan, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Yufeng Zhu, Mengru Tian, Maozhuo Lan, Mengtuan Long, Yun Dai, Fengyan Jin
Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study. Journal of hematology & oncology 17 (1) (2024)
Shanshan Liu, Hongwei Zhou, Weiling Xu, Tao Jin, Xinyue Liang, Xiaoxia Zhao, Yun Dai, Fengyan Jin
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma. Annals of hematology (2023)
Shanshan Liu, Hongwei Zhou, Weiling Xu, Tao Jin, Xinyue Liang, Xiaoxia Zhao, Yun Dai, Fengyan Jin
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma. Annals of hematology 102 (4) (2023)
Mengru Tian, Xinyue Liang, Weiling Xu, Xingcheng Yi, Tingting Yue, Yingjie Zhang, Shanshan Yu, Yurong Yan, Zhongli Hu, Nan Zhang, Jingxuan Wang, Rui Hu, Xiaoxiao Sun, Yuanyuan Nie, Yun Dai, Fengyan Jin
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma. Annals of hematology (2023)
Shanshan Liu, Hongwei Zhou, Weiling Xu, Tao Jin, Xinyue Liang, Xiaoxia Zhao, Yun Dai, Fengyan Jin
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma. Annals of hematology 102 (4) (2023)
Shanshan Liu, Hongwei Zhou, Weiling Xu, Tao Jin, Xinyue Liang, Xiaoxia Zhao, Yun Dai, Fengyan Jin
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma. Annals of hematology (2023)
Shanshan Liu, Hongwei Zhou, Weiling Xu, Tao Jin, Xinyue Liang, Xiaoxia Zhao, Yun Dai, Fengyan Jin
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma. Annals of hematology 102 (4) (2023)
Shanshan Liu, Hongwei Zhou, Weiling Xu, Tao Jin, Xinyue Liang, Xiaoxia Zhao, Yun Dai, Fengyan Jin
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma. Annals of hematology 102 (4) (2023)
Peiyu Yang, Weiling Xu, Xinyue Liang, Shanshan Yu, Xingcheng Yi, Mengmeng Liu, Mengru Tian, Tingting Yue, Yingjie Zhang, Yurong Yan, Zhongli Hu, Qiang Guo, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Rui Hu, Shaji K Kumar, Yun Dai, Fengyan Jin
Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma. American journal of hematology (2022)
Peiyu Yang, Fan Zhou, Yujun Dong, Guangxun Gao, Hua Xue, Xinyue Liang, Shanshan Yu, Weiling Xu, Yanping Ma, Xiaoqi Qin, Mengyao Li, Yun Dai, Fengyan Jin
The prognostic value of the MASS in a multi-center cohort of patients with newly diagnosed multiple myeloma. Blood cancer journal 12 (9) (2022)
Peiyu Yang, Weiling Xu, Xinyue Liang, Shanshan Yu, Xingcheng Yi, Mengmeng Liu, Mengru Tian, Tingting Yue, Yingjie Zhang, Yurong Yan, Zhongli Hu, Qiang Guo, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Rui Hu, Shaji K Kumar, Yun Dai, Fengyan Jin
Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma. American journal of hematology 98 (3) (2022)
Peiyu Yang, Weiling Xu, Xinyue Liang, Shanshan Yu, Xingcheng Yi, Mengmeng Liu, Mengru Tian, Tingting Yue, Yingjie Zhang, Yurong Yan, Zhongli Hu, Qiang Guo, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Rui Hu, Shaji K Kumar, Yun Dai, Fengyan Jin
Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma. American journal of hematology (2022)
Peiyu Yang, Weiling Xu, Xinyue Liang, Shanshan Yu, Xingcheng Yi, Mengmeng Liu, Mengru Tian, Tingting Yue, Yingjie Zhang, Yurong Yan, Zhongli Hu, Qiang Guo, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Rui Hu, Shaji K Kumar, Yun Dai, Fengyan Jin
Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma. American journal of hematology 98 (3) (2022)
Peiyu Yang, Haimin Chen, Xinyue Liang, Weiling Xu, Shanshan Yu, Wenyang Huang, Xingcheng Yi, Qiang Guo, Mengru Tian, Tingting Yue, Mengyao Li, Yingjie Zhang, Mengxue Zhang, Yurong Yan, Zhongli Hu, Shaji K Kumar, Fan Zhou, Yun Dai, Fengyan Jin
Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma. American journal of hematology (2022)
Peiyu Yang, Weiling Xu, Xinyue Liang, Shanshan Yu, Xingcheng Yi, Mengmeng Liu, Mengru Tian, Tingting Yue, Yingjie Zhang, Yurong Yan, Zhongli Hu, Qiang Guo, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Rui Hu, Shaji K Kumar, Yun Dai, Fengyan Jin
Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma. American journal of hematology 98 (3) (2022)
Peiyu Yang, Weiling Xu, Xinyue Liang, Shanshan Yu, Xingcheng Yi, Mengmeng Liu, Mengru Tian, Tingting Yue, Yingjie Zhang, Yurong Yan, Zhongli Hu, Qiang Guo, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Rui Hu, Shaji K Kumar, Yun Dai, Fengyan Jin
Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma. American journal of hematology 98 (3) (2022)
Fengyan Jin, Jian Li, Jianfeng Guo, Thorsten R Doeppner, Dirk M Hermann, Gang Yao, Yun Dai
Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis. European heart journal open 1 (2) (2021)
Xiao Ding, Wenyang Huang, Yi Peng, Hongqiong Fan, Yingqiao Zhu, Xuelian Liu, Yanping Yang, Qiang Guo, Lugui Qiu, Yun Dai, Dehui Zou, Fengyan Jin
Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma. Annals of hematology 99 (6) (2020)

Fengyan Jin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Fengyan Jin